A detailed history of Bvf Inc transactions in Immunic, Inc. stock. As of the latest transaction made, Bvf Inc holds 8,902,972 shares of IMUX stock, worth $11 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
8,902,972
Previous 8,902,972 -0.0%
Holding current value
$11 Million
Previous $11.8 Million 15.91%
% of portfolio
0.3%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.14 - $1.53 $10.1 Million - $13.6 Million
8,902,972 New
8,902,972 $11.8 Million
Q4 2022

Feb 14, 2023

BUY
$1.13 - $10.8 $1.3 Million - $12.4 Million
1,149,425 New
1,149,425 $1.61 Million

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $37.9M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.